Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
4 pending office actions • 3 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
ZYMO RESEARCH CORPORATION currently manages 4 pending office actions within the Biotechnology & Pharmaceuticals technology area. This portfolio is distributed across 3 distinct art units, indicating a focused but multi-disciplinary approach to patenting in the life sciences. The involvement of 4 distinct examiners suggests that the company's applications are being reviewed by a diverse set of perspectives within the USPTO, which can lead to varied feedback across the portfolio.
SODERQUIST, ARLEN is identified as the busiest examiner for this portfolio, currently handling 1 pending office action. This distribution shows that no single examiner is overwhelmed by the company's current filings, as the 4 pending office actions are spread among 4 distinct examiners. Practitioners should note that the 3 distinct art units may require different strategies for overcoming technical rejections, as each unit operates under its own specific guidelines and precedents. The distribution of pending matters across multiple reviewers ensures that each application receives independent consideration without being influenced by the same reviewer's previous decisions on other company filings.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 3 (75%) |
| Multi-statute (no §101) | 1 (25%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MCCORMACK, ERIN KATHLEEN | 1 | 8.6% | +50.0% |
| LEONARD, ARTHUR S | 1 | 50.8% | +50.2% |
| NGUYEN, QUANG | 1 | 38.0% | +52.6% |
| GREENE, CAROLYN LEE | 1 | 65.3% | +47.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17770601 | BIOLOGICAL SAMPLE COLLECTION PAD | MCCORMACK, ERIN KATHLEEN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 16933773 | NUCLEIC ACID PURIFICATION | NGUYEN, QUANG | 100d overdue |
| 16757297 | METHODS AND COMPOSITIONS FOR THE PURIFICATION OF UNBIASED RNA | GREENE, CAROLYN LEE | 9d |
| 17770601 | BIOLOGICAL SAMPLE COLLECTION PAD | MCCORMACK, ERIN KATHLEEN | — |
| 17554861 | METHODS FOR NUCLEIC ACID CAPTURE | LEONARD, ARTHUR S | — |
| Art Unit | Apps |
|---|---|
| 1631 | 2 |
| 3791 | 1 |
| 1681 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17770601 | BIOLOGICAL SAMPLE COLLECTION PAD | MCCORMACK, ERIN KATHLEEN | 3791 | §103§112 | Non-Final OA | — | Pending | Apr 20, 2022 |
| 17554861 | METHODS FOR NUCLEIC ACID CAPTURE | LEONARD, ARTHUR S | 1631 | §103 | Final Rejection | — | Pending | Dec 17, 2021 |
| 16933773 | NUCLEIC ACID PURIFICATION | NGUYEN, QUANG | 1631 | §103 | Final Rejection | 100d overdue | Pending | Jul 20, 2020 |
| 16757297 | METHODS AND COMPOSITIONS FOR THE PURIFICATION OF UNBIASED RNA | GREENE, CAROLYN LEE | 1681 | §103 | Non-Final OA | 9d | Pending | Apr 17, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial